You are hereBiblio / The Impact of Nanomedicine Development on North-South Equity and Equal Opportunities in Healthcare

The Impact of Nanomedicine Development on North-South Equity and Equal Opportunities in Healthcare


By csep - Posted on 12 September 2011

TitleThe Impact of Nanomedicine Development on North-South Equity and Equal Opportunities in Healthcare
Publication TypeJournal Article
Year of Publication2009
AuthorsTyshenko, Michael G.
JournalStudies in Ethics, Law, and Technology
Volume3
Issue3
Date Published12/2009
ISSN Number19416008
KeywordsDeveloping Nations and Nanotechnology, Medical Use
Abstract

Nanomedicine applications are an extension of traditional pharmaceutical drug development that are targeting the most pressing health concerns through improvements to diagnostics, drug delivery systems, therapeutics, equipment, surgery and prosthetics. The benefits and risks to the individual have been extrapolated to include broader societal impacts of nanomedicine with concerns extending to inequitable distribution of benefits accruing to developed, or North countries, rather than developing, or South countries. Analysis reveals a great deal of overlap between the North and South's most serious health priorities which kill millions each year. A significant amount of nanomedicine research activity is also underway for the most pressing South country-specific health concerns. Nanomedicine development promises profound breakthroughs for both North and South countries; however, the existing inequities in pharmaceutical drug development, patenting, access and delivery remain significant barriers for South countries.

URLhttp://www.bepress.com/selt/vol3/iss3/art2/
DOI10.2202/1941-6008.1118
Short TitleStudies in Ethics, Law, and Technology